Loading the records…
Loading the records…
BILL ANALYSIS
HR7478 (Patient Debt Relief Act) has been assessed with a bearish outlook for investors. The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.
bearish
Market Sentiment
4/10
Impact Score
1
Sectors Impacted
HR7478 imposes Medicare compliance costs and collection restrictions on hospitals with zero offsetting benefits for for-profits
HCA and UHS have already declined 9.2% and 6% respectively in the trailing 30 days as the market prices this risk
Bill is early-stage (referred to committee) with low near-term passage probability, but regulatory overhang may persist
The market is correctly discounting HCA and UHS on this regulatory threat. HCA at $429.70 is near its 52-week low of $330; UHS at $168.24 is near $152.33. Both have further downside if the bill gains committee momentum, but also have a potential catalyst for recovery if the bill dies in committee—a likely scenario given the divided Congress. Investors should monitor committee assignments and hearing schedules for Energy & Commerce and Ways & Means.
| Metric | Value |
|---|---|
| Bill Number | HR7478 |
| Market Sentiment | bearish |
| Event Date | |
| Affected Sectors | Healthcare |
| Source | View on Congress.gov → |
The Patient Debt Relief Act (HR7478) imposes new Medicare compliance costs on hospital operators without providing offsetting reimbursement benefits. For-profit chains HCA and UHS are directly exposed. The bill is early-stage, but both stocks have already declined significantly over the trailing 30 days as the market prices in the regulatory overhang.
Free — no credit card
HillSignal scores every bill, federal contract, and insider filing for market impact and emails you the high-conviction ones. Free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
© 2026 HillSignal. All rights reserved.
Not financial advice. For informational purposes only.